Introducing a New Feature to Rapidly Migrate Active Studies and Upgrade Your Trials

 
 
 

THREAD is excited to announce new capabilities designed to migrate studies from legacy systems to modernize their clinical research operations without pause.

Read the full press release >

Upgrading active clinical trials from legacy technologies has long been a complex challenge—fraught with risks of study team disruption, downtime, and compromised data quality. These new features will enable you to conduct your studies with greater flexibility, efficiency, and precision by seamlessly transitioning to a single configurable platform. Developed in close partnership with our clients and platform users, this innovative feature delivers:

  • Rapid transition from legacy platforms in hours, with a complete audit trail
  • Seamless participant experience at any study stage to ensure continuity
  • Universal data acceptance and processing from any legacy or partner system, regardless of format
  • Real-time operation with zero downtime for research sites, participants, and study teams

“Sponsors and CROs are turning to us to migrate from outdated systems, consolidate multiple platforms, and reduce overall clinical trial costs. Our solution offers a fully configurable, no-downtime path forward—built precisely to address the complexities of today’s trials,” said John Reites, Co-founder and CEO at THREAD.

Explore the latest THREAD platform release today. 

Learn More About This Latest Release
 
 
 

Explore the new features live on a quick call with a THREAD expert

Request a Quick Demo
 
 
 

Follow us or visit our website

 
WebsiteLinkedInTwitterYouTubeBluesky
 
 

167 E Chatham Street, Suite 300

Cary, North Carolina 27511

THREAD Newsletter Subscription

Preferences  |  Unsubscribe